Background-We imaged the protease activity of matrix metalloproteinases (MMPs) upregulated during aneurysm formation, using protease-activatable near-infrared fluorescence probes. We tested whether these protease-activatable sensors can directly report the in vivo activity of the key biomarkers in aneurysm, using our genetically modified fibulin-4 mouse models for aneurysm formation. Mice homozygous for the fibulin-4 reduced-expression allele (fibulin-4 R/R ) show dilatation of the ascending aorta and a tortuous, stiffened aorta resulting from disorganized elastic fiber networks. Strikingly, even a moderate reduction in expression of fibulin-4 in the heterozygous fibulin-4 ϩ/R mice occasionally results in modest aneurysm formation.
A thoracic aortic aneurysm (TAA) is a bulge in the aorta that can cause the diameter of the aorta to expand to several times its normal size. Such an aneurysm may rupture, leading to extensive internal bleeding that frequently is fatal. Aortic aneurysms can be identified with ultrasound imaging and treated by open or endovascular surgery once they have formed. However, the loss of vessel wall integrity that precedes aortic dilatation can be neither detected nor treated.
An essential protein for maintaining arterial integrity is the extracellular matrix (ECM) protein fibulin-4 (FBLN4). FBLN4 is an elastic fiber-associated glycoprotein involved in stabilizing the organization of ECM structures, such as elastic fibers and basement membranes. Complete elimination of FBLN4 in mice resulted in embryonic death due to arterial hemorrhage. 1 In a fibulin-4 knockdown mouse model, we have identified a dose-dependent requirement for FBLN4 for proper elastic fiber composition. 2 Mice homozygous for fibulin-4 reduced-expression allele (fibulin-4 R/R ) with a systemic 4-fold reduced fibulin-4 expression level show severe dilatation of the ascending aorta as well as a tortuous and stiffened aorta resulting from disorganized elastic fiber networks. Interestingly, already a modest 2-fold reduction in expression of FBLN4 in the heterozygous fibulin-4 ϩ/R mice has resulted in clear aberrations in elastin formation with occasionally small aneurysm formation. This milder phenotype of heterozygous fibulin-4 ϩ/R mice provides an informative aneurysm model system to delineate the early events in the pathogenetic sequence that culminate in aneurysm. The subtle manifestations of aberrant elastin formation in the fibulin-4 ϩ/R mice might resemble those patients with sporadic and barely detectable forms of aneurysms. Therefore, these fibulin-4 ϩ/R mice provide the opportunity to unravel the biological processes within early onset of aortic degeneration. This dose-dependent requirement for FBLN4 in the development of the elastic fibers in arteries recently has been confirmed using either heterozygous fibulin-4 ϩ/Ϫ mice 3 or a mouse model with a smooth muscle-specific Cre-mediated fibulin-4 deletion, 4 both causing a gradual disorganization of elastic laminae in the medial layer in the aortic wall.
Clinical Perspective on p 577
Transcriptome and protein expression analysis implicated perturbation of transforming growth factor-␤ (TGF-␤) signaling in the pathogenesis of aneurysm in fibulin-4-deficient mice. Analysis of aortic tissue from fibulin-4 ϩ/R and fibulin-4 R/R mice revealed a graded increase in TGF-␤ signaling compared to wild-type animals. Increased TGF-␤ signaling has been documented previously in the context of other well-established aortic aneurysm syndromes, including Marfan syndrome, Loeys-Dietz syndrome, and arterial tortuosity syndrome. 5, 6 The prominent perturbation of normal elastin lamellar structure may arise from induction of TGF-␤-regulated matrix metalloproteinases (MMPs), a family of zinc-dependent endopeptidases that are responsible for the degradation of the ECM in aortic aneurysms. 7, 8 Studies of aneurysm tissues from patients with Marfan syndrome suggest that upregulation of MMP-2 and MMP-9 also may play a primary role in Marfan syndrome. 9 Based on these data, we used our fibulin-4 knockdown mouse models to explore molecular imaging methods for the in vivo registration of MMP upregulation during aneurysm formation.
Optical imaging is an important new technology in translational medicine, and 3D quantitative techniques like fluorescence molecular tomography (FMT) emerged as powerful quantitative modalities for noninvasive whole-mouse imaging. 10, 11 Rapidly developing molecular sensing strategies permit visualization of key biological processes in aneurysm formation. In this investigation, we studied molecular imaging of upregulated MMP activity during aneurysm formation, using protease-activatable near-infrared fluorescence (NIRF) probes. These long-circulating protease-sensing optical probes that can be used to detect and quantitate protease activity are autoquench fluorescent probes that convert from a nonfluorescent state to a fluorescent state by proteolytic activation. This proteolytic activity comes from MMPs that can cleave an MMP-specific recognition sequence between the carrier and the fluorochromes of these probes. 12, 13 In this way, these protease-activatable sensors can directly report the in vivo activity of a key biomarker in aneurysm, such as MMP-9.
To be able to accurately localize the fluorescent signal obtained from a living mouse, reference imaging to visualize anatomy is required, which is achieved with micro-CT on the same animals performed immediately after FMT. With this hybrid approach of FMT-CT imaging, localization of MMP activity can be visualized in the different stages of aneurysm development and correlated with anatomic structures. These hybrid technologies where multiple modalities for both anatomic and functional imaging are combined become increasingly available and transform the imaging of vascular disease from a method of diagnosing to a tool for the noninvasive detection of early subclinical abnormalities. 14 At first, to carefully analyze and compare the overall vasculature between wild-type and fibulin-4 mice, we used contrastenhanced magnetic resonance angiography (MRA). 15 Clinically, 3D MRA is the imaging modality of choice for stable aortic disease. The increase in vascular signal that gadolinium (Gd)-based contrast agents provide when compared with unenhanced MRA allows for faster imaging with improved spatial resolution using 3D techniques, flow independent signal enhancement, and reduced magnetic susceptibility artifacts. Advantages of using MRI for vascular diagnosis include safety, noninvasive nature (except for when administering IV contrast agents), a wide field of view and imaging depth unimpaired by acoustic shadowing or beam-hardening artifact, and isotropic data collection, making it possible to show complicated 3D relationships using multiplanar reformats and 3D rendering. 16 The noninvasive and multicontrast capabilities of MRI were used to understand the pathology of the fibulin-4 mice.
In this study, we investigated methods identifying early aneurysm onset (using fibulin-4 ϩ/R ) and advanced aneurysms (fibulin-4 R/R ) in mature animals using protease-activatable NIRF probes in combination with optical quantitative in vivo detection methods and multimodality coregistration. Our studies indicate that this protease-activatable probe can be used to image MMP activity during both the onset and the maturation of aneurysm formation. This approach supersedes existing methods analyzing MMP levels and activity, such as zymography, immunohistochemistry, Western blotting, and scintigraphy, 17 because it enables reliable quantitative in vivo registration, allowing longitudinal analysis during treatment.
Methods

Mouse Model
Although complete fibulin-4 knockout mice have recently been generated and showed embryonic lethality, 1 we previously generated a fibulin-4 allele with reduced expression by transcriptional interference through placement of a thymidine kinase/neomycin-targeting construct in the downstream Mus81 gene. 2 Heterozygous fibulin-4 ϩ/R mice in a mixed C57Bl/6J;129Sv background were mated to generate the fibulin-4 ϩ/ϩ , fibulin-4 ϩ/R , and fibulin-4 R/R littermates analyzed in this study. Mice were kept in individually ventilated cages to keep them consistently microflora and disease free. To avoid stress-related vascular injury, mice were earmarked and genotyped 4 weeks after birth.
Histological Analysis
Mice (aged 120 days) were euthanized by an overdose of anesthesia or CO 2 , fixed by perfusion fixation with 4% formaldehyde, and underwent autopsy according to standard protocols (eg, European Union Mouse Research for Public Health and Industrial Applications protocol). Organ weights were determined and macroscopic abnormalities noted. Organs and tissues were fixed in formalin. Hearts and aortas of fibulin-4 ϩ/ϩ , fibulin-4 ϩ/R , and fibulin-4 R/R mice were isolated, and after removing fibrous connective tissue, macroscopical images were taken with a stereoscope. Aortas then were paraffin embedded, and 4-m sections were stained with hematoxylin and eosin, alcian blue for cartilage, and Verhoeff-Van Gieson for elastin. Immunohistochemistry for phosphorylated Smad2 (pSmad2) was performed as described previously 18, 19 using rabbit antiphosphosmad2 antibodies. Immunohistochemistry for MMP-9 (Santa Cruz) was performed on 6-m aortic cryosections of fibulin-4 ϩ/ϩ , fibulin-4 ϩ/R , and fibulin-4 R/R mouse aortas counterstained with hematoxylin.
Zymography
Protein was extracted from the mouse aortic arch. The samples were homogenized at 4°C in 350-L lysis buffer (50 mmol/L Tris-HCl; pH 8.8; 100 mmol/L NaCl; 1% sodium dodecyl sulfate; 1/25 protease inhibitor mix) using a rotor homogenizer. Next, lysis samples were spun down (10 minutes at 4000 rpm) and heated for 3 minutes at 55°C to denature the gelatinases. Samples were further homogenized by shearing through a 25-gauge needle. The protein content of the aortic samples was determined according to the method of Lowry et al, 20 and samples were equalized for protein content. Gelatin zymography was conducted using SDS-PAGE gels containing 1.0% gelatin. After electrophoresis, the gels were washed 2 times in a Triton X-100 solution (2.5%) to remove the sodium dodecyl sulfate and renature the gelatinases. Gels then were developed in development buffer (5 mmol/L CaCl 2 ; 50 mmol/L Tris-HCl; pH 8.8; 0.02% NaN 3 ) overnight at 37°C. Enzymatic activities were visualized as negative stainings with 0.1% Coomassie Brilliant Blue. The molecular sizes of gelatinolytic activity were determined by comparison with native molecular weight and quantified using ImageJ software. In situ zymography on 6-m aortic cryosections of fibulin-4 ϩ/ϩ , fibulin-4 ϩ/R , and fibulin-4 R/R mouse aortas was performed using quenched fluorogenic DQ gelatin as described by the manufacturer.
MRI and MRA
To fully understand the complex nature of aortic vascular pathology in fibulin-4 R/R mice, we used homemade Gd-liposomes (as previously described 21 ) as an intravascular contrast agent to acquire high-resolution whole-body MRA on a 3.0-T clinical MRI scanner with a 4-channel phased-array receiver interface providing an effective 7-cm cranial-caudal field of view. A 3D fat-suppressed T1-weighted scan (TR/TE, 41.7/2.8 milliseconds; flip angle, 40°, field of view, 60 mm; acquisition time, 35 minutes) was performed after the injection of the Gd-liposomes through the tail vein with an effective voxel resolution of 117ϫ187ϫ100 m 3 . Subsequently, MRAs were processed using surface-rendering 3D on the MRI scanner console to visualize the entire aorta from the aortic root to the branching of the iliac arteries.
In Vivo Lifetime Fluorescence Imaging
We used MMPSense 680, which according to supplier information can be activated in vitro in the presence of MMP-13, MMP-12, MMP-9, MMP-7, MMP-2, and MMP-1, to monitor the upregulation of MMPs in vivo. MMPSense 680 4 nmol was injected into the tail vein of 120-day-old fibulin-4 ϩ/ϩ , fibulin-4 ϩ/R , and fibulin-4 R/R male littermates. Twenty hours later, the anesthetized mice were scanned using the Optix MX2 optical imaging system. Excitation was performed with a 670-nm pulsing laser, and emission was detected with a 693-nm long-pass filter. Time-of-flight distribution enabled fluorescence lifetime to be determined. The scanning was performed over a Cartesian grid in prioritized raster fashion. The fluorescent intensity of the tissues was quantified using the Optiview version 2.2 software provided as part of the imaging package. Lifetime analysis was used to confirm the specificity of MMP-activated MMPSense 680. Fluorescence intensities and fluorescence lifetime were expressed in pseudo colors and projected on the bright field grayscale image of the mouse. Data analysis was performed using the Optiview 2.2 software to allow for background subtraction, and then lifetime analysis of MMPSense 680 was performed. The temporal dispersion of fluorescent photons is measured by time-correlated single-photon counting after excitation of the fluorophore by laser pulse. Analysis of this temporal dispersion curve, the fluorescent temporal point spread function, was used to verify the intensity of MMPSense 680 in the tissue. The fluorescent intensity value was gated (synchronized) at the fluorescent lifetime range as determined for MMPSense 680.
Macroscopic Ex Vivo Fluorescence Reflectance Imaging
Complete hearts with aortas attached were harvested after in vivo fluorescence imaging and analyzed using the FMT 2500 or Odyssey imaging systems. Near-infrared images were obtained in the 680-and 700-nm channels, respectively.
FMT-CT Imaging
We used vascular FMT-CT imaging as previously described. 22 In short, mice were shaved and depilated to remove all hair that otherwise would absorb light and interfere with optical imaging. Before FMT scanning, mice received 5 mL/kg body weight Exia 160 contrast agent through injection in the tail vein for subsequent CT analysis. FMT imaging of fibulin-4 mice was then performed using an FMT 2500 system at 680-and 700-nm excitation and emission wavelengths, respectively, at 20 hours after tail vein injection of 5 nmol of MMPSense 680. Mice were anesthetized (isoflurane, 1.5%; O 2 , 2 L/min) and fixed into the portable animal imaging cassette that lightly compressed the anesthetized mouse between optically translucent windows, thereby preventing motion during FMT and CT imaging. This multimodal animal holder facilitates coregistration of FMT to CT data through fiducial landmarks on its frame. The FMT 2500 quantitative tomography software was then used to calculate 3D fluorochrome concentration distribution of MMPSense 680. Immediately after FMT imaging, the animal holder with the anesthetized mouse was transferred to the micro-CT scanner to identify the heart and aortic root region of the animal. The CT x-ray source operated at 70 kV and 142 A, with an exposure time of 110 milliseconds to acquire 1500 projections (rotation steps of 0.7°). The effective 3D resolution was 35 m isotropic. We then imported data into CVP (Cyttron Visualization Platform), an in-house-developed image registration and visualization program to coregister FMT and CT images. Fiducial markers on the imaging cartridge were visualized and tagged in FMT and CT images with point markers to define their x, y, and z coordinates. Using these coordinates, data were resampled, rotated, and translated to match the image matrixes and finally displayed in 1 hybrid image.
Results
Fibulin-4 Mice as Model System for the Detection of Aneurysm-Specific Biomarkers
To fully understand the complex nature of aortic vascular pathology in fibulin-4 R/R mice, we performed MRI and MRA using Gd-liposomes as an intravascular contrast agent to acquire high-resolution whole-body angiograms. To be able to perform these experiments on a clinical MRI scanner, we developed a specialized receiver interface using 4 loop coils for signal reception. 23 MRAs were subsequently processed using a 3D reconstruction platform to visualize the entire aorta from the aortic root to the branching of the iliac arteries.
We compared the aortic arch and the descending aorta of wild-type, fibulin-4 ϩ/R , and fibulin-4 R/R mice ( Figure 1A ). Three-dimensional MRA reconstructions allowed accurate analysis of the TAA in fibulin-4 R/R mice. We observed variations in size and location of the TAA in the ascending aorta of fibulin-4 R/R mice. Tortuosity is clearly visible in the descending aorta and limited to the thoraceous part of the aorta. Surface rendering of high-resolution MRAs acquired in living fibulin-4 R/R mice not only showed aortic dilatation and a tortuous descending aorta, but also allowed detailed examination of the surrounding aorta, collateral vessels, and heart abnormalities (see Figure 1B and supplemental video I for 3D animation). Because careful examination of the collateral vessels revealed no other aberrations, we concluded that the vascular pathology we observed is highly specific for the thoraceous aorta. These fibulin-4 R/R mice, therefore, can be used as an attractive model for the in vivo detection of aneurysm-specific biomarkers.
We then compared the ex vivo morphology of the adult aorta of wild-type, fibulin-4 ϩ/R , and fibulin-4 R/R mice. All ) show an aortic dilatation and a tortuous descending aorta. B, Surface rendering of a high-resolution MRA acquired in a live mouse using intravascular Gd-liposomes.
homozygous fibulin-4 R/R mice showed a dramatic dilatation of the ascending aorta and a tortuous and stiffened aorta (Figure 2A, ϫ40) . Compared to wild-type mice, the aortas of fibulin ϩ/R mice were less translucent possibly because of increased deposition of amorphous ECM material and reactive cartilage proteoglycans as identified by alcian blue staining ( Figure 2B and 2C) . Thus, already a moderate 2-fold decrease in fibulin-4 expression results in aberrations of the aortic wall. Analysis of the elastic fiber network of the aorta of the fibulin-4 mice pointed to significant changes in the architecture of the elastic laminae, consisting of a granular appearance of elastin in the outer layers of the aorta in adult fibulin-4 R/R mice. In addition, the inner layers showed fragmentation and disarray of elastic fibers and increased thickness of the aortic wall ( Figure 2D ). Interestingly, fragmentation of elastic fibers, but not the granular appearance, also was observed in adult heterozygous fibulin-4 ϩ/R mice, indicating a gene-dosage effect of fibulin-4.
Disturbed TGF-␤ Signaling and MMP Upregulation in Fibulin-4 Mice
Aorta transcriptome analysis of fibulin-4 ϩ/R and fibulin-4 R/R animals identified excessive TGF-␤ signaling as the critical event in the pathogenesis of aneurysm formation. 2 We performed protein expression analysis by immunolabeling aortic tissue slices from the different mice. These stainings revealed an increase in TGF-␤ signaling compared to wild-type animals, as evidenced by increased phosphorylation and nuclear localization of Smad2 in fibulin-4 ϩ/R mice ( Figure  3A ). In addition, fibulin-4 R/R mice showed an increase in pSmad2. There were large areas that showed loss of vascular smooth muscle cells and severe thickening (data not shown).
From the elastin and immunostainings, we realized that this perturbed elastin lamellar structure in the fibulin-4 mice might have been caused by the induction of TGF-␤-regulated MMPs because we previously found MMPs upregulated in both fibulin-4 ϩ/R and fibulin R/R mice in our microarray expression analysis. 2 To determine whether and which MMPs are increased in aortas of fibulin-4 mice, we performed gelatin zymography. Homogenates of the aortic arches of fibulin-4 mice were generated and separated by SDS-PAGE, after which the gelatinolytic activity was determined. Based on the molecular weights, we conclude that the gelatinolytic activities were consistent with the presence of MMP-2 and MMP-9. Whereas both protein extracts of fibulin-4 ϩ/R and fibulin-4 R/R aortic arches showed an increase in MMP-2, densitometric analyses of the active form of MMP-9 also demonstrated a clear increase in the presence of the active form of MMP-9 in the aortic arch of fibulin-4 R/R mice ( Figure 3B and 3C) . Moreover, a decrease in pro-MMP-9 coincides with an increase of active MMP-9 in the fibulin-4 ϩ/R and fibulin R/R genotypes. To provide histological support for the increase in MMP-9 activity detected in the fibulin-4 ϩ/R and fibulin R/R genotypes, we performed in situ MMP-9 enzyme localization and MMP enzyme activity localization experiments. First, we performed MMP-9 peroxidase immunohistochemistry on cryosections of aortic slices of the different genotypes, which showed a gradual increase in MMP-9 levels in the medial layers of fibulin-4 ϩ/R and fibulin-4 R/R mouse aortas ( Figure  4A, left) . Second, to accurately localize the increase of MMP activity, we performed in situ zymography on cryosections, which showed a gradual increase in DQ gelatin-derived fluorescence throughout the aortic wall ( Figure 4A , DQ and fibulin-4 R/R mouse aortas. Immunohistochemical analysis reveals a graded increase in extent and nuclear localization of pSmad2 (an intracellular mediator of the TGF-␤ signal) in the aortic media of fibulin-4 ϩ/R and fibulin-4 R/R mice relative to wild-type fibulin-4 ϩ/ϩ mice. Indicated in parentheses is the average number of pSmad2-positive nuclei per slice in pSmad2-stained aortic slices covering the ascending aneurysmatic area (9 to 11 slices) from the aortic arch into the descending aorta for the different genotypes. A qualitatively similar gradual increase in pSmad2 was observed in an additional set of fibulin-4 mice of the indicated genotypes. B, Gelatin zymography of aortic arch homogenates of fibulin-4 mice. The molecular weights of the gelatinolytic activities were consistent with the presence of MMP-2 and MMP-9. C, Densitometric analyses of active MMP-9 demonstrated a strong increase in the presence of active MMP-9 in the aortic arch of fibulin-4 R/R mice.
gelatin; 4Ј,6-diamidino-2-phenylindole [DAPI]; and merged image). Third, we compared cryosections of aortas of mice injected with MMPSense 680, an MMP-specific activatable NIRF probe developed for in vivo imaging, with noninjected control aortas by confocal microscopy, which showed that both the elastin layers and the amorphous material between the layers showed increased NIRF after MMPsense 680 injections. From these experiments, we conclude that although there is a fibulin-4 dose-dependent increase in the MMP-9 protein levels in the medial layers of fibulin-4 ϩ/R and fibulin-4 R/R aortas, this results in an overall increase of fluorescence in the overall structure of the vessel, including the elastin layers, probably because of a local redistribution of the cleaved fluorescent MMPSense probe throughout the aortic wall.
In Vivo Imaging of MMP Activity in Aneurysmal Fibulin-4 Mice
MMP activity was monitored in vivo using MMPsense 680 after injection of this protease sensor into live mice. After excitation, fluorescent molecules can be characterized by their specific decay time from an excited to a ground state, known as their lifetime fluorescence. The measurement of this parameter was used to verify the signal intensity against background in the determination of MMP activity in the heart and aortic arch region during aneurysm formation. A weighted histogram showed that the lifetime of MMPSense 680 was centered around a maximum peak of 1.85 ns with a distribution curve of between 1.79 and 2.02 ns as shown on the histogram ( Figure 5A ). Figure 5B shows the localization and distribution of the 1.79-and 2.02-ns lifetime signal range for the fibulin-4 ϩ/R and fibulin-4 R/R genotypes. The specificity of the MMPSense 680 is indicated as intensity for fibulin-4 ϩ/R ( Figure 5C , left) and fibulin-4 R/R ( Figure 5C , right) genotypes, gated at a lifetime of between 1.79 and 2.02 ns. The total gated intensity (in normalized counts) showed an increase of MMPSense 680 activity in the fibulin-4 R/R genotype. Noninjected control mice had a lifetime of Ͻ1 ns in the aortic arch area, which underscores the specificity of the fluorescent MMPsense signal (data not shown).
After the in vivo imaging, the mice were euthanized, the hearts with the aortas attached excised, and ex vivo fluorescence in the aortic arch and aorta of the fibulin-4 mice compared using the Odyssey imaging system. We measured a Figure 4 . A, MMP-9 peroxidase immunohistochemistry on cryosections of aortic slices of the indicated genotypes and control tissue staining in which the primary MMP-9 antibody was excluded (left). To accurately localize the increase of MMP activity, in situ zymography was performed on aortic cryosections using DQ gelatin after which the sections were counterstained with DAPI (right, DQ gelatin, DAPI, and merged image). B, Confocal images of aortic cryosections of MMPSense 680-injected mice (24 hours prior preparation of the slices) and noninjected control sections. Both images are displayed on the same relative fluorescence intensity scale (0 to 255) in a stepwise rainbow color scale. Note that both the elastin layers and the amorphous material between the layers showed increased NIRF.
graded increase of MMPSense 680 activation in the fibulin-4 ϩ/R and fibulin-4 R/R mice compared to wild-type fibulin-4 ϩ/ϩ mice ( Figure 5D ). In wild-type fibulin-4 ϩ/ϩ mice, basic activity of the MMPSense 680 was primarily detected in the aortic arch region and reached a level of 19.75 relative fluorescence units. In the fibulin-4 ϩ/R and fibulin-4 R/R mice, an increasing amount of MMP-9 activity-induced fluorescence was detected in the dilated aortic arch and further down the extended descending aorta. Relative fluorescence units were increased to 26.53 and 105.77 for the fibulin-4 ϩ/R and fibulin-4 R/R mice, respectively. The fluorescent intensity of the aortas was quantified using the Odyssey software package. In conclusion, in vivo lifetime imaging of aneurysmal fibulin-4 mice and ex vivo analyses of the aortas of these animals demonstrated specific NIRF signals for MMP activity in fibulin-4 mice in the region of the aortic arch.
Three-Dimensional FMT-CT Coregistration Locates MMP Activation in the Aortic Arch
To accurately localize a fluorescent signal retrieved from a living mouse and identify the organ from which the fluorescence is emitted, reference imaging is needed to visualize anatomic detail. After we found that MRA revealed no other abnormalities in the vascular system than the aortic aneurysm, we switched to a less technically demanding imaging modality to acquire reference anatomy pictures. Using a micro-CT scanner dedicated for small animal imaging in combination with the vascular contrast agent Exia 160, we generated 3D data sets for the different fibulin-4 mice. CT angiography allowed us to identify and demonstrate an increased heart size and aortic aneurysm in the ascending aorta in the homozygous fibulin-4 R/R knockdown animals compared to the fibulin-4 ϩ/R mice ( Figure 6A ). Using the MMPSense 680, we monitored MMP activity in live animals using an FMT imaging system and coregistered the fluorescence signal with CT images of the same animals. To coregister FMT and CT data sets, mice were placed in a multimodal imaging cartridge containing fiducial markers detectable by both imaging modalities. Figure 6B 
Quantitative FMT Analysis Detects MMP Activation Before the Onset of Aneurysm Formation
Ex vivo analysis confirmed the observed in vivo-graded increase in MMPs within the aortic arches in fibulin-4 ϩ/R and fibulin-4 R/R mice compared to fibulin-4 ϩ/ϩ wild-type animals ( Figure 7A ). Through the FMT imaging modality, a direct comparison of isolated heart and aorta of the different genotypes showed that the graded increase in fluorescence evidently can be detected. Ultimately, we wanted to rigorously address whether we can detect upregulation of protease activity already in fibulin-4 ϩ/R mice. For that reason, we directly compared the MMP upregulation in fibulin-4 ϩ/ϩ and fibulin-4 ϩ/R ( Figure 7B and 7C and Table) . Finally, we performed a comparative analysis of 5 mice in total: 2 wild-type fibulin-4 ϩ/ϩ mice and 3 heterozygous fibulin-4 ϩ/R mice. Quantitative analysis confirmed the upregulation of MMP activity in all heterozygous fibulin-4 ϩ/R mice compared to wild-type fibulin-4 ϩ/ϩ animals analyzed by both FMT in vivo ( Figure 7C and 7D and Table) and 2D fluorescence imaging of the hearts and aortas ex vivo ( Figure  7C ). Whereas the absolute amount of the fluorescent signal of activated MMPsense 680 was 3 to 4 pmol, the fluorescence level of MMPSense 680 varied from 7 to 11 pmol per animal in the heterozygous mice. Importantly, these fibulin-4 ϩ/R mice did not display any detectable signs of aneurysm formation. The fluorescence level determined for MMPSense 680 in noninjected control mice imaged under the same FMT imaging settings was 0 pmol (data not shown). Figure 7D shows the qualitative analysis of MMP activity in the different mouse models after reconstruction of the tomographic images. Twenty hours after IV injection of the MMPSense 680 probe, we observed a graded increase in MMP activity in heterozygous fibulin-4 ϩ/R animals and homozygous fibulin-4 R/R animals compared to normal wild-type mice. A 3D FMT-CT reconstruction of the fluorescence and the CT signal of the same fibulin-4 ϩ/R mouse is depicted in Figure 7E and shows that although the diameter of the ascending aorta is unaffected, there is clear fluorescence detectable, pointing to MMP activity at this position (see supplemental video III for animation of 3D FMT-CT coregistration).
Discussion
The size and growth rate of an aortic aneurysm likely predicts the onset of risk for aortic dissection or rupture. 24, 25 In addition to conventional imaging modalities (eg, ultrasound imaging or CT), new diagnostic tools that interrogate the aneurysmatic lesion potentially could serve to test pathophysiological hypotheses to identify the risk while the disease remains undetected and to evaluate novel therapeutic strategies. Accumulating evidence mainly from in vitro studies implicates the increase in MMP activity, most notably MMP-9, in the disease state. 26 Although no conventional structural imaging technique can measure the protease level at the site of the aortic aneurysm, we tested whether NIRF protease-activatable probes to detect MMP action in vivo followed by quantitative assessment of the actual level of protease activity renders noninvasive macroscopic observation of aortic aneurysm staging in living mice feasible.
Our focus was to investigate early detection methods of aortic aneurysms using genetically modified mouse models for TAAs. The aortic arch is distinct from the other parts of the arterial tree, especially due to the presence of a large amount of elastic fibers. A critical component for the elasticity is the FBLN4 protein. Based on the knockdown of the fibulin-4 gene, we have recently developed mouse models displaying both mild and severe forms of aneurysm due to reduced amounts of FBLN4 protein. By a combination of pathological analyses and in vivo experiments, we demonstrated a reproducible aortic dilatation of the ascending aorta in the homozygous fibulin-4 R/R mice. Strikingly, already a modest 2-fold reduction in expression of FBLN4 in the heterozygous fibulin-4 ϩ/R mice occasionally resulted in aneurysm formation. 2 Here we show with a variety of molecular imaging methods using protease-activatable NIRF probes that the protease activity of MMPs becomes gradually upregulated during aneurysm formation. Using the MMPSense 680 probe, we monitored MMP activity in living animals using a FMT imaging system and coregistered the fluorescence signal with CT images of the same animals. We detected bright fluorescence in the homozygous fibulin-4 R/R knockdown animals at the position of the dilated aortic arch. However, already in the modestly affected heterozygous fibulin-4 ϩ/R animals, an increased activity of MMPs at the position of the nondilated aortic arch could be detected. C, Three-dimensional FMT-CT coregistration. To reliably identify the region of interest within the heart, FMT imaging was hybridized with CT imaging for anatomic reference. After completion of FMT, the animal fixed in the multimodal animal holder with fiducial markers was analyzed with CT. Within both data sets, fiducial points were tagged to define their x, y, and z coordinates. Using these coordinates, FMT data were then resampled, rotated, and translated to match the CT image matrix and finally fused. After identification of the aneurysm on CT, regions of interest were defined in both FMT channels.
Accurate 3D images are the key to quantitative analysis of fluorescence levels detected in the animals and, thus, the quantitative analysis of MMP activity. Previously, MMPactivatable probes have been used in vivo to detect MMP-2 and MMP-9 action noninvasively in macrophage-rich atherosclerotic aortas in hypercholesterolemic mice. 27 However, our genetically engineered fibulin-4 mouse models do not require induction of the aneurysm using either high-fat diet, causing atherosclerosis, or angiotensin-II infusion protocols 28 but spontaneously and highly reproducibly develop aortic aneurysm due to cystic medial degeneration. Thus, the MMP activation we detect is not atherosclerosis induced. Immunohistochemical analysis of aortic tissue from fibulin-4 ϩ/R and fibulin-4 R/R mice revealed a graded increase in TGF-␤ signaling compared to wild-type animals, as evidenced by increased phosphorylation and nuclear localization of Smad2 ϩ/R and fibulin-4 R/R mice compared to wild-type fibulin-4 ϩ/ϩ animals. Data are presented as the mean MMPSense 680 quantity (pmol), with bars indicating the SD (nϭ5). Statistical differences were determined using Student t test, and P values are shown between the different groups. E, Three-dimensional FMT-CT coregistration of the heart and aorta of a heterozygous fibulin-4 ϩ/R mouse. See also Figure 6C . FMT-derived fluorescence is measured in mean concentration (nM), and the absolute quantity of the excited fluorochrome is presented as pmol in the indicated volume.
indicative for increased TGF-␤ signaling. The mechanism by which fibulin-4 deficiency initiates excessive TGF-␤ signaling could reflect disruption of other elastic fiber components known to regulate TGF-␤, such as fibrillin-1 or emilin. 29, 30 TGF-␤ is synthesized as a latent complex consisting of the active TGF-␤ dimer, the latency-associated protein, and the latent TGF-␤ binding protein that is bound to fibrillin-1 in the ECM. 31 Latent TGF-␤ binding protein-mediated incorporation into the ECM is necessary for subsequent effective activation of TGF-␤. There are several mechanisms for activation, including proteolysis of the ECM proteins, such as fibrillin or latent TGF-␤ binding proteins. 32 MMP-2 has been shown to be involved in activation of TGF-␤ within the arterial wall. 33 In addition, cell surface-localized MMP-9 is capable of activating latent TGF-␤. 34 Because we show increased active MMP-2 and MMP-9 levels in the arterial walls of fibulin-4-deficient mice, these proteases could be involved in increased TGF-␤ activation. In contrast or in addition, TGF-␤ has been shown to upregulate both MMP-2 and MMP-9 expression in vitro. 35, 36 Moreover TGF-␤ levels have been shown to correlate to MMP-2 and MMP-9 expression in colorectal cancer. 18 So increased TGF-␤ activity also could be causally involved in increased MMP expression and, in turn, mediate increased TGF-␤ activation, creating a positive feedback loop.
Using MRA, we find combined manifestations of general aortic vascular pathology, including TAA, and a tortuous descending aorta. We observed variations in size and location of TAA in the ascending aorta of fibulin-4 R/R mice. Strikingly, we also noticed incidental cases of aortic coarctation (data not shown), a type of aortic pathology that in humans is also associated with aneurysm formation. 37 Although the unsurpassed resolution of Gd-liposome-enhanced MRI was extremely useful to analyze the location of the aneurysm and the presence of additional abnormalities in the collateral vessels in mice, CT imaging was the modality of choice to routinely determine aortic root diameter and to perform multimodality imaging.
Following FMT by micro-CT imaging, the upregulation of this MMP biomarker was compared with the actual increase in aneurysmal size, and a consistent upregulation of MMP activity in all fibulin-4 ϩ/R animals was detected. Fusing the 3D optical images with CT images from the same animal allowed us to obtain structural anatomic information, enhancing spatial resolution. This multimodal approach of molecular sensing by FMT and anatomic CT imaging, including fiducial markers in the field of view, is a promising and useful quantitative imaging modality that has recently been applied to detect protease activity in atherosclerotic lesions of apoliprotein E Ϫ/Ϫ mice 22 and amyloid-␤ plaques in a mouse model of Alzheimer disease. 38 In this study, we show that this hybrid method based on FMT fluorescence measurements combined with CT anatomic information is an important tool for in vivo imaging of aneurysmal disease progression within a single mouse. Information from studies like these could provide real-time evaluation of the efficacy therapeutic treatments, such as angiotensin II/angiotensin type 1 receptor blockage treatments by losartan. 39 By using the same method at several spectral windows, with corresponding fluorochromes or expressed fluorescent proteins emitting at different spectral bands, different aneurysmal disease biomarkers, such as cathepsins or changes in renin-angiotensin levels, could be visualized simultaneously.
Our aim was to develop molecular imaging procedures for faster, earlier, and easier recognition of aneurysms. We show here that in vivo coregistration of MMP activity and vascular pathology, using quantitative FMT imaging and contrastenhanced CT imaging, allows the detection of increased MMP activity before the aneurysm has actually formed. This study reveals that TGF-␤-induced MMP activity is a leading indicator for (nonatherosclerotic) aneurysm formation and that this key biomarker for aortic aneurysm can be monitored in vivo.
